Abstract
Modification of spinal serotonergic receptors caudal to spinal injury occurs in rats that received spinal cord transections as neonates. Evaluation of the serotonin syndrome, a group of motor stereotypies elicited by serotonergic (5-HT) agents in 5-HT-depleted animals, and open field locomotor behavior were used to assess behavioral consequences of injury and treatment. We extend these findings to show that a partial 5-HT(1A) agonist activity is revealed by the 5-HT(2C) receptor antagonist (SB 206,553) in this animal model, as measured by evaluation of serotonin syndrome behavior. Treadmill stimulation enhances this motor response, caudal to the injury, in the hindlimbs and tail. These results imply a broader modification of serotonergic receptors than previously thought and suggest a potential strategy by which serotonergic agents may enhance functional recovery following neonatal injury.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Animals, Newborn
-
Behavior, Animal / drug effects
-
Disease Models, Animal
-
Female
-
Indoles / pharmacology*
-
Male
-
Motor Activity / drug effects
-
Piperazines / pharmacology
-
Pyridines / pharmacology*
-
Rats
-
Rats, Sprague-Dawley
-
Serotonin 5-HT1 Receptor Agonists*
-
Serotonin 5-HT1 Receptor Antagonists
-
Serotonin 5-HT2 Receptor Antagonists*
-
Serotonin Antagonists / pharmacology*
-
Serotonin Receptor Agonists / pharmacology*
-
Serotonin Syndrome / chemically induced
-
Serotonin Syndrome / physiopathology
-
Spinal Cord Injuries / drug therapy
-
Spinal Cord Injuries / physiopathology*
Substances
-
Indoles
-
Piperazines
-
Pyridines
-
Serotonin 5-HT1 Receptor Agonists
-
Serotonin 5-HT1 Receptor Antagonists
-
Serotonin 5-HT2 Receptor Antagonists
-
Serotonin Antagonists
-
Serotonin Receptor Agonists
-
N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
-
SB 206553